Critical Path Institute Announces Expansion of Regulatory Science Consortium For Tuberculosis Critical Path Institute is proud to announce that the Regulatory Science Consortium, an arm of the Critical Path to TB Drug Regime
Critical Path Institute President and CEO Plans To Retire in 2012 Critical Path Institute’s Board of Directors today announced that President, CEO, and Chairman of the Board, Raymond L. Woos
Critical Path Institute and Clinical Data Interchange Standards Consortium Host International Program At New Training Facility Joint efort to advance data standards and create public databases as means o accelerate medical product development
Critical Path Institute And Clinical Data Interchange Standards Consortium Announce Innovative Partnership To Address Major Diseases Global leaders join forces to establish data standards and create public data bases as new means to accelerate medical product dev
Executive director of Critical Path Institute’s Coalition Against Major Diseases testifies before congress on Alzheimer’s disease progress Marc Cantillon, MD, presents the critical role of public/private partnerships in creating innovative tools to advance the developm
Alfred M. Cohen, MD, FACS, FASCRS, Joins as Director, Cancer Biosignature Programs Alfred M. Cohen, MD, FACS, FASCRS, has joined Critical Path Institute (C-Path) as Director of its Cancer Biosignature Programs.
Martha Brumfield, PhD, Hired as Director, International Programs Martha Brumfield, PhD, has joined Critical Path Institute (C-Path) as Director of International Programs.
Leading Pharmacologist and Pharmaceutical Scientist Joins Critical Path Institute Thorir D. Bjornsson, MD, PhD, has joined Critical Path Institute as a member of its Board of Directors, and will also lead one of
Leading Neuroscientist Joins Critical Path Institute Marc Cantillon, MD, has joined Critical Path Institute as Executive Director of one of its major consortia, the Coalition Against
